Amicus Therapeutics
Amicus Therapuetics is a biotechnology company developing therapies to cure rare diseases.
All edits by Andrey Pyankov
Edits on 30 Apr, 2019
Andrey Pyankov
Edits made to:
Article (+25/-25 characters)
Article
On September 8, 2005 Amicus Therapeutics completed their series C funding round with $55 million in funding from Quaker BioVentures (lead investor), Radius Ventures, Prospect Venture PartnersProspect Venture Partners, Palo Alto Investors, New Enterprise Associates, Garden State Life Sciences Venture, Frazier Healthcare Partners, Canaan Partners, and CHL Medical Partners.
Find more companies like Amicus Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.